These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28920929)

  • 21. NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells.
    Zou Q; Tan S; Yang Z; Zhan Q; Jin H; Xian J; Zhang S; Yang L; Wang L; Zhang L
    Theranostics; 2017; 7(8):2289-2304. PubMed ID: 28740552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergic role of nucleophosmin three-helix bundle and a flanking unstructured tail in the interaction with G-quadruplex DNA.
    Arcovito A; Chiarella S; Della Longa S; Di Matteo A; Lo Sterzo C; Scaglione GL; Federici L
    J Biol Chem; 2014 Aug; 289(31):21230-41. PubMed ID: 24952945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
    Vascotto C; Lirussi L; Poletto M; Tiribelli M; Damiani D; Fabbro D; Damante G; Demple B; Colombo E; Tell G
    Oncogene; 2014 May; 33(22):2876-87. PubMed ID: 23831574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias.
    Mullighan CG; Kennedy A; Zhou X; Radtke I; Phillips LA; Shurtleff SA; Downing JR
    Leukemia; 2007 Sep; 21(9):2000-9. PubMed ID: 17597811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the recognition by 14-3-3 proteins of a conditional binding site within the oligomerization domain of human nucleophosmin.
    Kapitonova AA; Tugaeva KV; Varfolomeeva LA; Boyko KM; Cooley RB; Sluchanko NN
    Biochem Biophys Res Commun; 2022 Oct; 627():176-183. PubMed ID: 36041327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleophosmin in leukemia: Consequences of anchor loss.
    Brodská B; Šašinková M; Kuželová K
    Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
    Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
    Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
    Du Pisani LA; Shires K
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b.
    Zou Q; Tan S; Yang Z; Wang J; Xian J; Zhang S; Jin H; Yang L; Wang L; Zhang L
    Oncotarget; 2016 Nov; 7(44):71477-71490. PubMed ID: 27669739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia.
    Forghieri F; Riva G; Lagreca I; Barozzi P; Vallerini D; Morselli M; Paolini A; Bresciani P; Colaci E; Maccaferri M; Gilioli A; Nasillo V; Messerotti A; Pioli V; Arletti L; Giusti D; Bettelli F; Celli M; Donatelli F; Corradini G; Basso S; Gurrado A; Cellini M; Trenti T; Marasca R; Narni F; Martelli MP; Falini B; Potenza L; Luppi M; Comoli P
    Oncotarget; 2019 Jan; 10(8):869-882. PubMed ID: 30783516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis.
    Zhang MJ; Ding YL; Xu CW; Yang Y; Lian WX; Zhan YQ; Li W; Xu WX; Yu M; Ge CH; Ning HM; Li CY; Yang XM
    FEBS J; 2012 Aug; 279(16):2848-62. PubMed ID: 22712502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the biology of acute myeloid leukemia with mutated NPM1.
    Brunetti L; Gundry MC; Goodell MA
    Int J Hematol; 2019 Aug; 110(2):150-160. PubMed ID: 30632059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
    Falini B; Sportoletti P; Martelli MP
    Curr Opin Oncol; 2009 Nov; 21(6):573-81. PubMed ID: 19770764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
    Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
    J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acute myeloid leukemia-associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain.
    La Manna S; Scognamiglio PL; Roviello V; Borbone F; Florio D; Di Natale C; Bigi A; Cecchi C; Cascella R; Giannini C; Sibillano T; Novellino E; Marasco D
    FEBS J; 2019 Jun; 286(12):2311-2328. PubMed ID: 30921500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.
    Zhou Y; Moon A; Hoyle E; Fromm JR; Chen X; Soma L; Salipante SJ; Wood BL; Wu D
    Cytometry B Clin Cytom; 2019 Jan; 96(1):67-72. PubMed ID: 30417521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
    Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
    Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Research on NPM1 gene mutations in acute myeloid leukemia].
    Chen HY; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):258-62. PubMed ID: 23484732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deguelin induced differentiation of mutated NPM1 acute myeloid leukemia in vivo and in vitro.
    Zhang X; Zhao Z; Yi S; Wen L; He J; Hu J; Ruan J; Fang J; Chen Y
    Anticancer Drugs; 2017 Aug; 28(7):723-738. PubMed ID: 28471807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
    Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
    Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.